Laid the foundation of Adley Group by Late Shri. Vijay Batra
Who We Are
Committed to Oncology
Because, every moment of life is precious for cancer patients
We at Beta Drugs Ltd, Strive for Affordability Accessibility Acceptability of medicines
"From the beginning, he realized that if medicine had to serve their purpose, they first had to be affordable & accessible".
Late Shri. Vijay Batra (1954-2021)
The Journey of Beta Drugs Limited (Adley Group) began in early 80's with the ardent efforts of Late Shri Vijay Batra. He was a visionary and businessman par excellence. He had foreseen the scope in niche segment like Oncology and laid the foundation of Indian Pharma Multinational in Oncology segment.
As guided by him, company is focusing on new product development. Comapany is set to launch 25 new products by year 2026 that includes NIB's, NDDS & PARP Inhibitors. His guiding force behind all the corporate decisions lead Beta Drugs Limited to achieve new heights over the years & became one of the most respected Oncology company in India.
To achieve a sustainable leadership in complex chemical synthesis for Anti-Cancer bulk drugs and finishes dosages.
To touch the lives of millions of cancer patients by expanding access to Quality & affordable drugs through cutting edge technology and advance R&D.
We believe healthcare is only effective when it’s affordable, hence we put in extra efforts in ensuring that we make cost effective products by achieving economy of scale and backward integration.
Collaboration & Partnerships
We firmly believe, Success is best when it’s shared and hence we consider everyone who associates with us i.e. patients, industry partners, and the communities associated with us, as partners.
We care about the well-being of our patients, care givers, and the communities we touch. We care about our colleagues, creating a respectful, inclusive and a diverse working environment.
We understand patients, and how fighting a disease takes a toll on them, so every step we take is in the direction to try and make this fight easier, by focusing on driving better treatment outcomes and not compromising on quality & affordability.
Value through innovation
We constantly innovate to create better value for our patients, our partners in the healthcare system and our stakeholders. We persistently focus on originality and try to find better ways to excel by creating products for current and future unmet needs.
Focus & Accountability
We believe that as leaders we set the right example by focusing diligently on everything we do by defining clear objectives, efforts and attention to deliver. We always hold ourselves accountable to the promises we make through our products & research.
Leading the Way
We are passionate about being first to market and realizing opportunities, but we also ensure that we lead by example as leadership happens through and with the people.
Entered into Oncology Market
Setup the first Oncology Unit in Adley Formulations Pvt Ltd.
Foray into the international market
Setup a new "state of the art" manufacturing facility for oncology formulations.
Developed in-house Albumin bound Paclitaxel.
Received SME Excellence Award
Listed in NSE - National Stock Exchange
Commenced In-house API Plant - Adley Labs
Setup an oncology plant in Uzbekistan.
Setup Inhouse PFS Facility
Launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB
Launched 1st Indian Brand of Dasatinib, BEEDAN
Launched 1st Indian brand of Sunitinib, ADSUNIB.